Medical Devices News and Research

RSS

Fidelitas launches dispensing and documentation system for methadone treatment

Fidelitas Medical IT-Solutions, LP announced today the launch of their product DDS, a dispensing and documentation system for methadone treatment.

18 Feb 2012

CMS urged to limit definition of research for reporting under Physician Payment Sunshine Act

Expressing concerns that many physicians will be discouraged from conducting medical research because of cumbersome reporting requirements and potential mischaracterizations of their income, the Association of Clinical Research Organizations (ACRO) is urging the Centers for Medicare & Medicaid Services to adopt a limited definition of research for purposes of reporting under the Physician Payment Sunshine Act.

18 Feb 2012

Sensors in Design conference to take place on March 28-29

2012 kicks off the inaugural Design West event in San Jose, CA featuring the Sensors in Design summit. The Sensors in Design conference is set to take place on March 28-29, 2012, featuring sessions lead by the top sensor fabricators as well as leading companies utilizing sensor technology in order to enhance functionality and interactivity in their products.

18 Feb 2012

Capsule to feature IHE-compliant connectivity solution at HIMSS12 Interoperability Showcase

Capsule Tech, Inc., the leading provider of medical device connectivity, announced its successful participation at the IHE (Integrating the Healthcare Enterprise) North America Connectathon that was held earlier this year in Chicago.

18 Feb 2012

Federal probe of FDA's treatment of whistleblowers widens

Investigators say they are broadening their efforts because of "new and troubling allegations."

18 Feb 2012

Aeroneb drug delivery products receive marketing authorisation in China

Aerogen,the innovative medical device and drug delivery company, has announced receipt of authorisation to market its Aeroneb Pro and Aeroneb Go products in China.

17 Feb 2012

FDA approves Medtronic's Resolute Integrity DES to treat CAD

Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.

From Medtronic 17 Feb 2012

Greatbatch acquires NeuroNexus

Greatbatch, Inc., today announced the acquisition of NeuroNexus Technologies for approximately $12 million in cash, including the assumption of debt and future considerations.

17 Feb 2012

Acorda's fourth quarter GAAP net income increases to $12.7 million

Acorda Therapeutics, Inc. today announced its financial results for the fourth quarter and full year ended December 31, 2011.

16 Feb 2012

ICON fourth quarter net revenues increase 5% to $242.6 million

ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the full year and fourth quarter ended December 31, 2011.

16 Feb 2012

St. Jude Medical to examine cost-effectiveness of FFR-guided therapy in Australia, Asia

St. Jude Medical, Inc., a global medical device company, announced today it will evaluate the incremental cost-effectiveness of Fractional Flow Reserve (FFR)-guided treatment for patients with multivessel coronary artery disease in Japan, China, India, Korea, and Australia.

15 Feb 2012

GAO finds big disparities in prices of some medical devices

News outlets examine a variety of health workplace issues, including a GAO report on medical device prices and efforts to get health workers vaccinated for the flu.

14 Feb 2012

Premier healthcare alliance awards new agreements for feeding pumps, sets, tubes and devices

The Premier healthcare alliance today announced new agreements for feeding pumps, sets, tubes and devices have been awarded to Abbott Nutrition of Columbus, Ohio; CORPAK MedSystems Inc. of Buffalo Grove, Ill.; Covidien of Mansfield, Mass.; Kimberly-Clark Global Sales LLC of Roswell, Ga.; and Moog Inc. Medical Devices Group of Salt Lake City, Utah.

13 Feb 2012

Medasys Prometra programmable implantable drug pump receives FDA PMA approval

Medasys Inc., a medical device company focused on providing implantable drug delivery solutions, announced today that it has received PMA approval from the U. S. Food and Drug Administration for its Prometra programmable implantable drug pump.

13 Feb 2012

Proven Process, OnCore enter medical product design alliance

OnCore Manufacturing Services, LLC, a leading provider of electronic manufacturing services (EMS), today announced its intention to enter into a medical product design alliance with Proven Process Medical Devices, Inc.

10 Feb 2012

Gerresheimer revenue increases 6.8% to EUR 1094.7m

Gerresheimer AG, one of the leading global partners to the pharma and healthcare industry, has closed the 2011 financial year with strong growth in revenues and profits. "Our revenues and profits have developed very positively in 2011.

8 Feb 2012

State roundup: Legislatures, govs juggling costs and health programs

Medicaid spending is a matter of urgency almost everywhere in the country right now, but in few places is the urgency as palpable as it is here, where the governor refers to the federal-state health insurance program for the poor as "welfare," says it's necessary to eliminate coverage for 65,000 adults, and wants to stop paying room and board for some 2,000 elders who live in group homes. All these ideas are part of Republican Governor Paul LePage's plan to close a $220 million hole in the state's biennial Medicaid budget.

7 Feb 2012

Fogarty Institute's Advanced Endovascular Training Fellowship to begin on July 1

The Fogarty Institute for Innovation announced today that it has launched its Advanced Endovascular Training Fellowship. This unique, year-long clinical training program for postgraduate physicians, which begins July 1, 2012, will provide Fellows with broad exposure to all aspects of endovascular patient care, with an emphasis on interventional training.

7 Feb 2012

Emergent Financial Group raises $11.8M for Tenex Health

Emergent Financial Group, Inc. today announced the completion of a $11.8 million private placement transaction for Tenex Health Inc., a California-based medical technology company developing the FAST Procedure (Focused Aspiration of Scar Tissue) for the treatment of tendon injuries.

6 Feb 2012

Positive clinical results from randomized trial of InspireMD's MGuard in STEMI patients

InspireMD, Inc., a medical device company focusing on the development and commercialization of its proprietary stent platform technology for use in patients with Acute Myocardial Infarctions, announced positive clinical results from an investigator-sponsored controlled randomized trial conducted in Chile.

6 Feb 2012